Abstract
Design: Patients are seen for laboratory evaluation and physical examination every 6 months, bone age yearly, DEXA and spine film every 2 years. They will be followed until they reach their final height. This is a preliminary report after 1 year of treatment. Setting: A single academic children's hospital outpatient clinic. Patients: Boys with age >10 years, bone age ≤14 years, clinical and hormonal evidence of central puberty, and either height
Cite
CITATION STYLE
Neely, E. K., Kumar, R. B., Payne, S. L., Ranadive, S. A., & Suchet, D. I. (2014). Letrozole vs anastrozole for height augmentation in short pubertal males: First year data. Journal of Clinical Endocrinology and Metabolism, 99(11), 4086–4093. https://doi.org/10.1210/jc.2014-2432
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.